Search
for

    Sort by

    Research 91–120 of 1000+

    1. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    2. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    3. Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia Egyptian Journal of Dermatology and Venereology · 2020 · 1 citations
    4. 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성 2003
    5. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    6. An observational study of the association between androgenetic alopecia and size of the prostate International Journal of Trichology · 2016 · 6 citations
    7. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study Urology · 1999 · 65 citations
    8. Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase. PubMed · 2005 · 38 citations
    9. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    10. PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice Canadian Urological Association Journal · 2012 · 13 citations
    11. Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids Biosensors · 2022 · 2 citations
    12. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    13. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    14. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование Курский научно-практический вестник "Человек и его здоровье" · 2012
    15. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    16. Finasteride in Androgenic Alopecia Journal of the Dermatology Nurses’ Association · 2016 · 1 citations
    17. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    18. Merck offers money back guarantee on finasteride BMJ · 1994 · 5 citations
    19. Comparison of clinical trials with finasteride and dutasteride. PubMed · 2004 · 20 citations
    20. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    21. Clinical use of 5α-reductase inhibitors Cambridge University Press eBooks · 2001 · 3 citations
    22. Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico Gazzetta Medica Italiana Archivio per le Scienze Mediche · 2026
    23. Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPH in rats 2025
    24. Experience of using of Sonirid Duo in treatment of patients with BPH Urology reports (St - Petersburg) · 2013
    25. Клинико-морфологическая характеристика ПЖ на фоне лечения ингибиторами 5-альфаредуктазы при ДГПЖ Земский врач · 2012
    26. Les Visiteurs des malades Nature Clinical Practice Urology · 2011
    27. Successes and failures of evidence based urology 2005
    28. Finasteride en de preventie van prostaatcarcinoom Medisch-Farmaceutische Mededelingen · 2004
    29. Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity Anti-Cancer Agents in Medicinal Chemistry · 2009 · 73 citations
    30. MP73-14 TRANSURETHRAL RESECTION URINARY RETENTION PREDICTOR (TURP) SCORE: A NOVEL PERIOPERATIVE PREDICTOR OF POST-OPERATIVE URINARY RETENTION 2018